Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLFS NYSE:ELMD NYSE:INSP NASDAQ:PRCT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLFSBioLife Solutions$27.79-1.1%$24.78$17.86▼$30.00$1.37B1.941.03 million shs550,790 shsELMDElectromed$46.31+1.9%$35.97$17.73▼$46.73$383.45M0.565,195 shs137,144 shsINSPInspire Medical Systems$49.47+5.4%$44.43$38.91▼$147.03$1.35B0.711.01 million shs1.17 million shsPRCTPROCEPT BioRobotics$21.21+0.9%$24.99$19.35▼$62.17$1.20B0.871.68 million shs1.41 million shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLFSBioLife Solutions0.00%-1.90%+5.48%+45.87%+20.85%ELMDElectromed0.00%+9.58%+20.54%+92.42%+118.62%INSPInspire Medical Systems0.00%+2.86%+13.70%-13.23%-63.43%PRCTPROCEPT BioRobotics0.00%-6.78%-24.43%-11.56%-64.36%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLFSBioLife Solutions$27.79-1.1%$24.78$17.86▼$30.00$1.37B1.941.03 million shs550,790 shsELMDElectromed$46.31+1.9%$35.97$17.73▼$46.73$383.45M0.565,195 shs137,144 shsINSPInspire Medical Systems$49.47+5.4%$44.43$38.91▼$147.03$1.35B0.711.01 million shs1.17 million shsPRCTPROCEPT BioRobotics$21.21+0.9%$24.99$19.35▼$62.17$1.20B0.871.68 million shs1.41 million shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLFSBioLife Solutions0.00%-1.90%+5.48%+45.87%+20.85%ELMDElectromed0.00%+9.58%+20.54%+92.42%+118.62%INSPInspire Medical Systems0.00%+2.86%+13.70%-13.23%-63.43%PRCTPROCEPT BioRobotics0.00%-6.78%-24.43%-11.56%-64.36%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLFSBioLife Solutions 2.40Hold$32.0015.15% UpsideELMDElectromed 3.25Buy$37.50-19.02% DownsideINSPInspire Medical Systems 2.14Hold$81.0563.84% UpsidePRCTPROCEPT BioRobotics 2.38Hold$40.0088.59% UpsideCurrent Analyst Ratings BreakdownLatest ELMD, BLFS, PRCT, and INSP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/2/2026PRCTPROCEPT BioRobotics Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy ➝ Hold$30.00 ➝ $25.007/2/2026PRCTPROCEPT BioRobotics CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold6/30/2026INSPInspire Medical Systems Freedom CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy6/24/2026PRCTPROCEPT BioRobotics EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$30.006/24/2026PRCTPROCEPT BioRobotics EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy$30.006/23/2026INSPInspire Medical Systems EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOutperform ➝ In-Line$40.006/15/2026INSPInspire Medical Systems OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingMarket Perform6/15/2026INSPInspire Medical Systems Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSector Perform ➝ Buy6/11/2026PRCTPROCEPT BioRobotics Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOutperform ➝ Market Perform$31.00 ➝ $29.005/22/2026INSPInspire Medical Systems Summit RedstoneSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$39.005/22/2026INSPInspire Medical Systems Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeNeutral ➝ Underperform$39.00(Data available from 7/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLFSBioLife Solutions$96.21M14.11$0.23 per share122.76$7.72 per share3.60ELMDElectromed$71.75M5.34$1.12 per share41.36$5.10 per share9.08INSPInspire Medical Systems$911.98M1.56$3.02 per share16.39$26.88 per share1.84PRCTPROCEPT BioRobotics$322.02M3.75N/AN/A$6.55 per share3.24Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLFSBioLife Solutions-$4.59M-$0.08N/A173.69N/A-2.80%1.81%1.65%8/6/2026 (Estimated)ELMDElectromed$5.15M$1.1761.75N/AN/A11.34%15.71%13.37%N/AINSPInspire Medical Systems$145.42M$4.4911.0234.594.7514.33%10.35%8.81%8/3/2026 (Estimated)PRCTPROCEPT BioRobotics-$95.57M-$1.82N/AN/AN/A-31.82%-27.70%-20.29%8/5/2026 (Estimated)Latest ELMD, BLFS, PRCT, and INSP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/3/2026Q2 2026INSPInspire Medical Systems-$0.21N/AN/AN/A$194.67 millionN/A5/7/2026Q1 2026BLFSBioLife Solutions$0.01$0.04+$0.03$0.02$25.66 million$27.50 million5/4/2026Q1 2026INSPInspire Medical Systems-$0.2753$0.10+$0.3753-$0.39$200.04 million$204.58 million4/29/2026Q1 2026PRCTPROCEPT BioRobotics-$0.55-$0.56-$0.01-$0.56$80.52 million$83.13 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBLFSBioLife SolutionsN/AN/AN/AN/AN/AELMDElectromedN/AN/AN/AN/AN/AINSPInspire Medical SystemsN/AN/AN/AN/AN/APRCTPROCEPT BioRoboticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLFSBioLife SolutionsN/A7.305.50ELMDElectromedN/A5.104.74INSPInspire Medical SystemsN/A6.344.48PRCTPROCEPT BioRobotics0.156.735.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLFSBioLife Solutions93.24%ELMDElectromed40.82%INSPInspire Medical Systems94.91%PRCTPROCEPT BioRobotics89.46%Insider OwnershipCompanyInsider OwnershipBLFSBioLife Solutions2.20%ELMDElectromed10.50%INSPInspire Medical Systems2.20%PRCTPROCEPT BioRobotics6.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLFSBioLife Solutions44048.86 million47.78 millionOptionableELMDElectromed1608.28 million7.36 millionOptionableINSPInspire Medical Systems1,33328.81 million28.18 millionOptionablePRCTPROCEPT BioRobotics43056.92 million47.02 millionOptionableELMD, BLFS, PRCT, and INSP HeadlinesRecent News About These CompaniesAnalysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Guardant Health (GH)2 hours ago | theglobeandmail.comEvercore Initiates PROCEPT BioRobotics (PRCT) At “Outperform,” Cites Aquablation Growth PotentialJune 29, 2026 | insidermonkey.comHere is Why PROCEPT BioRobotics (PRCT) is Amongst the Best Robotics and Automation Names Right NowJune 25, 2026 | finance.yahoo.comIs PROCEPT BioRobotics Corporation (PRCT) A Good Stock To Buy Now?June 19, 2026 | insidermonkey.comBiondo Investment Advisors LLC Reduces Stock Position in PROCEPT BioRobotics Corporation $PRCTJune 14, 2026 | marketbeat.comRhenman & Partners Asset Management AB Boosts Stock Position in PROCEPT BioRobotics Corporation $PRCTJune 13, 2026 | marketbeat.comProcept BioRobotics shares slide after Leerink downgrade cites rising competitive risksJune 12, 2026 | msn.comPROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 8.6% on Analyst DowngradeJune 11, 2026 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Rating Lowered to Market Perform at Leerink PartnersJune 11, 2026 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) EVP Sells $10,167.36 in StockJune 11, 2026 | insidertrades.comPROCEPT BioRobotics Shareholders Back Board, Pay and AuditorJune 10, 2026 | tipranks.comFiera Capital Corp Boosts Holdings in PROCEPT BioRobotics Corporation $PRCTJune 9, 2026 | marketbeat.comBTIG Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)June 6, 2026 | theglobeandmail.comPROCEPT BioRobotics Corporation (PRCT) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks TranscriptJune 2, 2026 | seekingalpha.comPROCEPT BioRobotics (PRCT) Receives a Buy from TD CowenJune 2, 2026 | theglobeandmail.comPROCEPT BioRobotics (PRCT) Is Down 9.2% After Aquablation WATER IV Milestones - What's ChangedJune 1, 2026 | finance.yahoo.comProcept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollmentMay 28, 2026 | massdevice.comPROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE ApprovalMay 28, 2026 | globenewswire.comHere’s What the Street Thinks About PROCEPT BioRobotics Corporation (PRCT)May 26, 2026 | finance.yahoo.com5 Robotics Stocks to Watch as Physical AI Builds Momentum (PRCT)...May 18, 2026 | marketbeat.comAUA Guidelines Strengthen Recommendation for Aquablation® TherapyMay 14, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeELMD, BLFS, PRCT, and INSP Company DescriptionsBioLife Solutions NASDAQ:BLFS$27.79 -0.32 (-1.14%) Closing price 04:00 PM EasternExtended Trading$28.10 +0.31 (+1.11%) As of 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.Electromed NYSE:ELMD$46.31 +0.88 (+1.94%) Closing price 04:00 PM EasternExtended Trading$46.31 +0.00 (+0.00%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.Inspire Medical Systems NYSE:INSP$49.47 +2.52 (+5.37%) Closing price 03:59 PM EasternExtended Trading$49.44 -0.02 (-0.05%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.PROCEPT BioRobotics NASDAQ:PRCT$21.21 +0.18 (+0.86%) Closing price 04:00 PM EasternExtended Trading$21.49 +0.28 (+1.32%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore KBR Insiders Are Buying While the Market Misreads Its Spinoff Doug Casey Calls AI a Super Bubble, Bets on Energy, Gold Miners and Grains Contrarian Alert: 5 Downgraded Stocks That May Reward Long-Term Investors This Edge AI Stock Just Got a Huge Vote of Confidence From Wall Street AI Is Selling Off, But These 5 Stocks Could Benefit Next MarketBeat Week in Review – 06/29 - 07/03 Analysts Just Raised Price Targets On These 3 Semiconductor Equipment Stocks Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
